Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...

New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from ...

TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 ...

Vertex Pharmaceuticals' stem cell therapy, Zimislecel, has shown potential to cure Type-1 diabetes, achieving insulin independence in 83% of patients during clinical trials.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...